BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 27, 2003
View Archived Issues
SARS in the intellectual portfolios
Read More
CDP-870 in active Crohn's disease
Read More
Visilizumab reported effective in severe ulcerative colitis
Read More
HCT-1026 is better tolerated than flurbiprofen
Read More
Good safety and efficacy profile found for lubiprostone in constipation
Read More
Sleep improvement induced by eszopiclone in chronic insomniacs
Read More
New protein kinase/phosphatase inhibitors and their use for preventing hearing loss
Read More
GSK claims orexin receptor antagonists for obesity, sleep disorders and stroke
Read More
Pierre Fabre presents novel dopamine D2 receptor modulators in recent patent
Read More
Sodium channel blockers isolated by Meiji Seika from Aspergillus
Read More
Novel DPP-IV inhibitors in early development at Roche
Read More
Alpha2C-adrenoceptor antagonists with utility in Parkinson's disease
Read More
Integrin-targeted antitumor agents designed at Scripps Research Institute
Read More
New antitumor Ras signaling modulators developed at Morphochem
Read More
Ventavis receives positive opinion in Europe
Read More
Valcyte completes European mutual recognition procedure for CMV prevention
Read More
Safety phase of lactoferrin study completed
Read More
Positive final phase II results for MBP-8298 in MS
Read More
OctoPlus and CytImmune to develop TNF with gold-based drug delivery system
Read More
ThromboGenics completes phase I trial of microplasmin for thromboembolic diseases
Read More
Calblock launched in Japan
Read More
Chalcones inhibit eosinophil recruitment, degranulation and survival via VCAM-1 inhibition
Read More
Novel class of compounds for asthma with antiinflammatory/antiadhesion properties
Read More
Selective herpesvirus agent presented by Charterhouse
Read More
TD-6424: a semisynthetic glycopeptide with excellent activity against Gram-positive bacteria
Read More